Management of type 2 diabetes mellitus in the elderly: Role of the pharmacist in a multidisciplinary health care team

Journal of Multidisciplinary Healthcare

Volumn 4, Issue , 2011, Pages 149-154

  Grossman, Samuel ^a,b,c,d,e  

^a DEPARTMENT OF VETERANS AFFAIRS   (United States)

^b Diabetes Care On The Go Inc   (United States)

^c CITY UNIVERSITY OF NEW YORK   (United States)

^d LONG ISLAND UNIVERSITY   (United States)

^e Garden State Association of Diabetes Educators   (United States)

Author keywords

Continuity of care; Elderly; Glycemic control; Hyperglycemia; Hypertension and cardiovascular disease; Pharmacist; Type 2 diabetes

Indexed keywords

EID: 84255163852     PISSN: None     EISSN: 11782390     Source Type: Journal    
DOI: 10.2147/JMDH.S21111     Document Type: Article

References (25)

1. American Diabetes Association. Standards of medical care in diabetes – 2011. Diabetes Care. 2011;34(Suppl 1):S11–S61
2. Sloan FA, Bethel MA, Ruiz D Jr, Shea AH, Feinglos MN. The growing burden of diabetes mellitus in the US elderly population. Arch Intern Med. 2008;168:192–199
3. Suh DC, Kim CM, Choi IS, Plauschinat CA. Comorbid conditions and glycemic control in elderly patients with type 2 diabetes mellitus, 1988 to 1994 to 1999 to 2004. J Am Geriatr Soc. 2008;56:484–492
4. Joslin Diabetes Center and Joslin Clinic. Guideline for the care of the older adult with diabetes. Available from: http://www.joslin.org/docs/ Guideline_For_Care_Of_Older_Adults_with_Diabetes.pdf. Accessed March 21, 2011
5. Fera T, Bluml BM, Ellis WM. Diabetes Ten City Challenge: final economic and clinical results. J Am Pharm Assoc (2003). 2009;49:383–391
6. Whitmer RA, Karter AJ, Yaffe K, Quesenberry CP Jr, Selby JV. Hypoglycemic episodes and risk of dementia in older patients with type 2 diabetes mellitus. JAMA. 2009;301:1565–1572
7. American Association of Clinical Endocrinologists. Medical guidelines for clinical practice for the management of diabetes mellitus. Endocr Pract. 2007;13(Suppl 1):4–68
8. Boyd CM, Darer J, Boult C, Fried LP, Boult L, Wu AW. Clinical practice guidelines and quality of care for older patients with multiple comorbid diseases: implications for pay for performance. JAMA. 2005;294:716–724
9. California Healthcare Foundation. Guidelines for improving the care of the older person with diabetes mellitus. J Am Geriatr Soc. 2003; 51(5 Suppl):S265–S280
10. Ahmed N, Mandel R, Fain MJ. Frailty: an emerging geriatric syndrome. Am J Med. 2007;120:748–753
11. Stratton IM, Adler AI, Neil HA, et al. Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study. BMJ. 2000;321:405–412
12. Nathan DM, Buse JB, Davidson MB, et al. Medical management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy. A consensus statement of the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care. 2009;32:193–203
13. Tibaldi J. Importance of postprandial glucose levels as a target for glycemic control in type 2 diabetes. South Med J. 2009;102: 60–66
14. Chau D. Clinical management of diabetes in the elderly. Clin Diabetes. 2001;19:172–175
15. Abbatecola AM, Maggi S, Paolisso G. New approaches to treating type 2 diabetes mellitus in the elderly: role of incretin therapies. Drugs Aging. 2008;25:913–925
16. White J. Efficacy and safety of incretin based therapies: clinical trial data. J Am Pharm Assoc (2003). 2009;49(Suppl 1):S30–S40
17. Spollett G. Insulin devices: addressing barriers to insulin therapy with the ideal pen. Diabetes Educ. 2008;34:957–967
18. Li Y, Xu W, Liao Z, et al. Induction of long-term glycemic control in newly diagnosed type 2 diabetic patients is associated with improvement of beta-cell function. Diabetes Care. 2004;27:2597–2602
19. Bolen S, Wilson L, Vassy J, et al. Comparative effectiveness and safety of oral diabetes medications for adults with type 2 diabetes. Comparative effectiveness review. Rockville, MD: Agency for Healthcare Research and Quality; 2007
20. Blonde L, Brixner D, Jacobs M. The rationale for early, aggressive treatment of type 2 diabetes: the cost ramifications of improved health outcomes. Managed Care. 2004;13(Suppl):S4–S21
21. Lee WC, Balu S, Cobden D, Joshi AV, Pashos CL. Medication adherence and the associated health-economic impact among patients with type 2 diabetes mellitus converting to insulin pen therapy: an analysis of thirdparty managed care claims data. Clin Ther. 2006;28:1712–1725
22. Bray B. Transitioning and adjusting insulin analog therapy in elderly patients. Consultant Pharm. 2008;23(Suppl B):17–23
23. Wubben DP, Vivian EM. Effects of pharmacist outpatient interventions on adults with diabetes mellitus: a systematic review. Pharmacotherapy. 2008;28:421–436
24. Cranor CW, Bunting BA, Christensen DB. The Asheville Project: longterm clinical and economic outcomes of a community pharmacy diabetes care program. J Am Pharm Assoc (Wash). 2003;43:173–184
25. Jameson JP, Baty PJ. Pharmacist collaborative management of poorly controlled diabetes mellitus: a randomized controlled trial. Am J Manag Care. 2010;16:250–255.